Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Langerhans cell histiocytosis

S Ladisch1

  • 1Children's Research Institute, George Washington University School of Medicine, Washington, DC 20010, USA.

Current Opinion in Hematology
|March 27, 1998
PubMed
Summary

Langerhans cell histiocytosis (LCH) involves abnormal cell growth. Treatment varies by disease extent, but its exact cause and nature (reactive vs. neoplastic) remain unknown, requiring further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.

Oncogene·2010
Same author

[Stable transfection of DAOY cells with a GM3 synthase antisense construct and transient reduction in ganglioside content].

Biomeditsinskaia khimiia·2006
Same author

Risk factors for diabetes insipidus in langerhans cell histiocytosis.

Pediatric blood & cancer·2005
Same author

Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid.

British journal of cancer·2004
Same author

Chromosomal transformation in donor cells following allogeneic bone marrow transplantation.

Bone marrow transplantation·2004
Same author

Antisense to integrin alpha v inhibits growth and induces apoptosis in medulloblastoma cells.

Anticancer research·2002

Area of Science:

  • Immunology
  • Oncology
  • Pathology

Background:

  • Histiocytosis encompasses disorders of mononuclear phagocyte and dendritic cell systems.
  • Langerhans cell histiocytosis (LCH) is characterized by proliferating Langerhans cells.
  • Established diagnostic criteria exist for LCH.

Purpose of the Study:

  • To review the clinical pathology, treatment strategies, and etiological controversies of LCH.
  • To highlight the need for further research into LCH pathogenesis.

Main Methods:

  • Review of existing literature on LCH.
  • Analysis of clinical presentations and treatment outcomes.
  • Discussion of etiological debates.

Main Results:

  • LCH presents as direct organ involvement or secondary damage (e.g., diabetes insipidus, fractures).
  • Therapy is tailored: single-system LCH may be treated with biopsy or mild chemotherapy; multisystem LCH requires combination chemotherapy.
  • The etiology of LCH is unknown, with ongoing debate on whether it is reactive or neoplastic.

Conclusions:

  • Treatment strategies for LCH depend on disease extent.
  • The unknown etiology and debated nature of LCH necessitate continued investigation into its pathogenesis.

Related Experiment Videos